Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist

Nicolas Damond, Fabrizio Thorel, Julie S. Moyers, Maureen J. Charron, Patricia M. Vuguin, Alvin C. Powers, Pedro L. Herrera

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds